Olga Corazón Irizarry1, Lisa D Levine1, Jennifer Lewey2, Theresa Boyer3, Valerie Riis1, Michal A Elovitz1, Zolt Arany2. 1. Maternal and Child Health Research Center, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia. 2. Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia. 3. Zanvyl Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore, Maryland.
Abstract
Importance: Peripartum cardiomyopathy (PPCM) disproportionately affects women of African ancestry, but well-powered studies to explore differences in severity of disease and clinical outcomes are lacking. Objective: To compare the clinical characteristics, presentation, and outcomes of PPCM between African American and non-African American women. Design, Setting, and Participants: This retrospective cohort study using data from January 1, 1986, through December 31, 2016, performed at the University of Pennsylvania Health System, a tertiary referral center serving a population with a high proportion of African American individuals, included 220 women with PPCM. Main Outcomes and Measures: Demographic and clinical characteristics and echocardiographic findings at presentation, as well as clinical outcomes including cardiac recovery, time to recovery, cardiac transplant, persistent dysfunction, and death, were compared between African American and non-African American women with PPCM. Results: A total of 220 women were studied (mean [SD] age at diagnosis, 29.5 [6.6] years). African American women were diagnosed with PPCM at a younger age (27.6 vs 31.7 years, P < .001), were diagnosed with PPCM later in the postpartum period, and were more likely to present with a left ventricular ejection fraction less than 30% compared with non-African American women (48 [56.5%] vs 30 [39.5%], P = .03). African American women were also more likely to worsen after initial diagnosis (30 [35.3%] vs 14 [18.4%], P = .02), were twice as likely to fail to recover (52 [43.0%] vs 24 [24.2%], P = .004), and, when they did recover, recovery took at least twice as long (median, 265 vs 125.5 days; P = .02) despite apparent adequate treatment. Conclusions and Relevance: In a large cohort of women with well-phenotyped PPCM, this study demonstrates a different profile of disease in African American vs non-African American women. Further work is needed to understand to what extent these differences stem from genetic or socioeconomic differences and how treatment of African American patients might be tailored to improve health outcomes.
Importance: Peripartum cardiomyopathy (PPCM) disproportionately affects women of African ancestry, but well-powered studies to explore differences in severity of disease and clinical outcomes are lacking. Objective: To compare the clinical characteristics, presentation, and outcomes of PPCM between African American and non-African American women. Design, Setting, and Participants: This retrospective cohort study using data from January 1, 1986, through December 31, 2016, performed at the University of Pennsylvania Health System, a tertiary referral center serving a population with a high proportion of African American individuals, included 220 women with PPCM. Main Outcomes and Measures: Demographic and clinical characteristics and echocardiographic findings at presentation, as well as clinical outcomes including cardiac recovery, time to recovery, cardiac transplant, persistent dysfunction, and death, were compared between African American and non-African American women with PPCM. Results: A total of 220 women were studied (mean [SD] age at diagnosis, 29.5 [6.6] years). African American women were diagnosed with PPCM at a younger age (27.6 vs 31.7 years, P < .001), were diagnosed with PPCM later in the postpartum period, and were more likely to present with a left ventricular ejection fraction less than 30% compared with non-African American women (48 [56.5%] vs 30 [39.5%], P = .03). African American women were also more likely to worsen after initial diagnosis (30 [35.3%] vs 14 [18.4%], P = .02), were twice as likely to fail to recover (52 [43.0%] vs 24 [24.2%], P = .004), and, when they did recover, recovery took at least twice as long (median, 265 vs 125.5 days; P = .02) despite apparent adequate treatment. Conclusions and Relevance: In a large cohort of women with well-phenotyped PPCM, this study demonstrates a different profile of disease in African American vs non-African American women. Further work is needed to understand to what extent these differences stem from genetic or socioeconomic differences and how treatment of African American patients might be tailored to improve health outcomes.
Authors: Karen Sliwa; Denise Hilfiker-Kleiner; Mark C Petrie; Alexandre Mebazaa; Burkert Pieske; Eckhart Buchmann; Vera Regitz-Zagrosek; Maria Schaufelberger; Luigi Tavazzi; Dirk J van Veldhuisen; Hugh Watkins; Ajay J Shah; Petar M Seferovic; Uri Elkayam; Sabine Pankuweit; Zoltan Papp; Frederic Mouquet; John J V McMurray Journal: Eur J Heart Fail Date: 2010-08 Impact factor: 15.534
Authors: Richard Sheppard; Eileen Hsich; Julie Damp; Uri Elkayam; Angela Kealey; Gautam Ramani; Mark Zucker; Jeffrey D Alexis; Benjamin D Horne; Karen Hanley-Yanez; Jessica Pisarcik; Indrani Halder; James D Fett; Dennis M McNamara Journal: Circ Heart Fail Date: 2016-03 Impact factor: 8.790
Authors: Dennis M McNamara; Uri Elkayam; Rami Alharethi; Julie Damp; Eileen Hsich; Gregory Ewald; Kalgi Modi; Jeffrey D Alexis; Gautam V Ramani; Marc J Semigran; Jennifer Haythe; David W Markham; Josef Marek; John Gorcsan; Wen-Chi Wu; Yan Lin; Indrani Halder; Jessica Pisarcik; Leslie T Cooper; James D Fett Journal: J Am Coll Cardiol Date: 2015-08-25 Impact factor: 24.094
Authors: Lisa D Levine; Hillary R Bogner; Adi Hirshberg; Michal A Elovitz; Mary D Sammel; Sindhu K Srinivas Journal: Am J Obstet Gynecol Date: 2013-10-30 Impact factor: 8.661
Authors: Ian S Patten; Sarosh Rana; Sajid Shahul; Glenn C Rowe; Cholsoon Jang; Laura Liu; Michele R Hacker; Julie S Rhee; John Mitchell; Feroze Mahmood; Philip Hess; Caitlin Farrell; Nicole Koulisis; Eliyahu V Khankin; Suzanne D Burke; Igor Tudorache; Johann Bauersachs; Federica del Monte; Denise Hilfiker-Kleiner; S Ananth Karumanchi; Zoltan Arany Journal: Nature Date: 2012-05-09 Impact factor: 49.962
Authors: James S Ware; Jian Li; Erica Mazaika; Christopher M Yasso; Tiffany DeSouza; Thomas P Cappola; Emily J Tsai; Denise Hilfiker-Kleiner; Chizuko A Kamiya; Francesco Mazzarotto; Stuart A Cook; Indrani Halder; Sanjay K Prasad; Jessica Pisarcik; Karen Hanley-Yanez; Rami Alharethi; Julie Damp; Eileen Hsich; Uri Elkayam; Richard Sheppard; Angela Kealey; Jeffrey Alexis; Gautam Ramani; Jordan Safirstein; John Boehmer; Daniel F Pauly; Ilan S Wittstein; Vinay Thohan; Mark J Zucker; Peter Liu; John Gorcsan; Dennis M McNamara; Christine E Seidman; Jonathan G Seidman; Zoltan Arany Journal: N Engl J Med Date: 2016-01-06 Impact factor: 91.245
Authors: Karen Sliwa; Mark C Petrie; Peter van der Meer; Alexandre Mebazaa; Denise Hilfiker-Kleiner; Alice M Jackson; Aldo P Maggioni; Cecile Laroche; Vera Regitz-Zagrosek; Maria Schaufelberger; Luigi Tavazzi; Jolien W Roos-Hesselink; Petar Seferovic; Karin van Spaendonck-Zwarts; Amam Mbakwem; Michael Böhm; Frederic Mouquet; Burkert Pieske; Mark R Johnson; Righab Hamdan; Piotr Ponikowski; Dirk J Van Veldhuisen; John J V McMurray; Johann Bauersachs Journal: Eur Heart J Date: 2020-10-14 Impact factor: 29.983
Authors: Anna E Bortnick; Claudia Lama von Buchwald; Aliaskar Hasani; Christina Liu; Julia L Berkowitz; Shayna Vega; Mohammad Hashim Mustehsan; Diana S Wolfe; Cynthia Taub Journal: Echocardiography Date: 2021-05-08 Impact factor: 1.724